Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genetics Generation Advancement Corp. (4160:TWSE), powered by AI.
Genetics Generation Advancement Corp. is currently trading at $41.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genetics Generation Advancement Corp. on Alpha Lenz.
View Genetics Generation Advancement Corp.'s valuation metrics on Alpha Lenz.
“Genetics Generation Advancement Corp.'s ROE is 3.7%. Explore profitability and growth together.”
Ask for details →Genetics Generation Advancement Corp. is a healthcare company specializing in diagnostics and genetic testing services, headquartered in Taipei, Taiwan. Its primary function is to provide a comprehensive suite of genetic and informatics testing solutions, spanning from pre-implantation and prenatal screening to newborn medical examinations, health management, and reproductive medicine assessments. The company also extends its expertise to specialized diagnostics in obstetrics, gynecology, neonatology, pediatrics, gastroenterology, hepatology, oncology, and broader medical research. In addition to testing, Genetics Generation Advancement Corp. is active in life sciences and material sciences, offering research and development management, enterprise quality management, and solutions for process production operation and digital data management systems. Established in 2008, it plays a significant role in supporting precision medicine and health technology sectors within Taiwan's healthcare industry. By integrating advanced genomics and informatics, the firm contributes to improving early disease detection, personalized treatment, and the overall advancement of biomedical research in the region.
“Genetics Generation Advancement Corp.'s ROE is 3.7%. Explore profitability and growth together.”
Ask for details →Genetics Generation Advancement Corp. (ticker: 4160) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).
The current price is 41.1 with a P/E ratio of -x and P/B of -x.
ROE is 3.70% and operating margin is 2.12%. Annual revenue is $603M.